TalkMed Completes Disposal Hong Kong Integrated Oncology Centre
With a 85% Stake, TalkMed Group Limited (SGX:5G3) Insiders Have a Lot Riding on the Company
TalkMed Advances CAR-T Therapy Manufacturing
TalkMed Group Advises Caution Amidst Acquisition Talks
Investors Met With Slowing Returns on Capital At TalkMed Group (SGX:5G3)
TalkMed: Financial Statements and Related Announcement-Half Yearly Results
TalkMed Continues Preliminary Discussions Over Acquisition
TalkMed's Subsidiary Enters Sale and Purchase Agreement to Dispose Shares in Unit
TalkMed in Preliminary Acquisition Talks
TalkMed Group Cautions Shareholders Amid Acquisition Talks
Investors in TalkMed Group (SGX:5G3) Have Unfortunately Lost 5.0% Over the Last Five Years
TalkMed Group Hosts 11th Annual General Meeting
TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal
TalkMed Group Settles High Court Litigation
Here's Why We Think TalkMed Group (SGX:5G3) Might Deserve Your Attention Today
TalkMed Group Signals Potential Acquisition Talks
Is TalkMed Group Limited's (SGX:5G3) Stock Price Struggling As A Result Of Its Mixed Financials?
TalkMed Group Awards 1.1 Million New Shares
TalkMed's H2 Attributable Profit Falls on Wider Impairment Loss
TalkMed Group Grants Nearly 8 Million Share Awards Under Performance Share Plan
No Data